| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |